ホーム>>Signaling Pathways>> Apoptosis>> Bcl-2 Family>>(E)-Ferulic acid

(E)-Ferulic acid

カタログ番号GC34980

(E)-フェルラ酸は、植物細胞壁に豊富に存在する芳香族化合物であるフェルラ酸の異性体です。 (E)-フェルラ酸はβ-カテニンのリン酸化を引き起こし、β-カテニンのプロテアソーム分解を引き起こし、アポトーシス促進因子Baxの発現を増加させ、生存促進因子サバイビンの発現を減少させます。 (E)-フェルラ酸は、活性酸素種 (ROS) を除去する強力な能力を示し、脂質過酸化を阻害します。 (E)-フェルラ酸は、ヒト肺癌細胞株 H1299 で抗増殖効果と抗遊走効果の両方を発揮します。

Products are for research use only. Not for human use. We do not sell to patients.

(E)-Ferulic acid 化学構造

Cas No.: 537-98-4

サイズ 価格 在庫数 個数
10mM (in 1mL DMSO)
$39.00
在庫あり
100mg
$35.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(E)-Ferulic acid is a isomer of Ferulic acid which is an aromatic compound, abundant in plant cell walls. (E)-Ferulic acid causes the phosphorylation of β-catenin, resulting in proteasomal degradation of β-catenin and increases the expression of pro-apoptotic factor Bax and decreases the expression of pro-survival factor survivin. (E)-Ferulic acid shows a potent ability to remove reactive oxygen species (ROS) and inhibits lipid peroxidation. (E)-Ferulic acid exerts both anti-proliferation and anti-migration effects in the human lung cancer cell line H1299[1]. Bax

[1]. Fong Y, et al. Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability. Chin Med. 2016 Oct 1;11:45.

レビュー

Review for (E)-Ferulic acid

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (E)-Ferulic acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.